Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 10
Submit an article Journal homepage
394
Views
5
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program

Pier Luigi ZinzaniInstitute of Hematology “L. E A. Seràgnoli”, University of Bologna, Bologna, Italy; Correspondence[email protected]
,
Cinzia PellegriniInstitute of Hematology “L. E A. Seràgnoli”, University of Bologna, Bologna, Italy;
,
Giuseppe CercielloAOU Policlinico Federico II, Napoli, Italy;
,
Federico MonacoA.O. SS Antonio E Biagio E Cesare Arrigo, Alessandria, Italy;
,
Stefano VolpettiCentro Trapianti E Terapie Cellulari Azienda Ospedaliero-Universitaria, Udine, Italy;
,
Annalisa PeliDepartment of Hematology, Spedali Civili, Brescia, Italy;
,
Emanuele AngelucciUO Ematologia E Centro Trapianti, Ospedale Oncologico Di Riferimento Regionale “Armando Businco”, Azienda Ospedaliera “Brotzu”, Cagliari, Italy;
,
Paolo CorradiniIstituto Nazionale Dei Tumori, Università Di Milano, Milano, Italy;
,
Maria Christina CoxHematology Unit, Sant'andrea Hospital, Roma, Italy;
,
Attilio GuariniNatl Cancer Center “Istituto Tumori Giovanni Paolo II IRCCS”, Bari, Italy;
,
Maurizio MussoOncohematology and Bone Marrow Unit, Oncology Department, La Maddalena, Palermo, Italy;
,
Paola BrescianiDepartment of Medical and Surgical Sciences, UNIMORE, AOU Policlinico, Modena, Italy;
,
Gabriella AmatoOncology and Hematology Department, IOM Istituto Oncologico Del Mediterraneo, Viagrande, Catania, Italy;
,
Atto BillioHematology and BMT, Central Hospital, Bolzano, Italy;
,
Giuseppe CaparrottiDivision of Hematology, San Giuseppe Moscati Hospital, Aversa, Caserta, Italy;
,
Amalia FigueraDivision of Hematology, AOU Policlinico-Vittorio Emanuele, Catania, Italy;
,
Luca NassiDivision of Hematology, Department of Translational Medicine Amedeo Avogadro University of Eastern Piedmont and Maggiore Hospital, Novara, Italy;
,
Francesco GaudioDepartment of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, University of Bari, Bari, Italy;
,
Alberto GrossiIstituto Fiorentino Di Cura E Assistenza, Firenze, Italy;
,
Francesco OnidaOnco-Hematology, BMT Center Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico University of Milan, Milano, Italy;
,
Michele MerliOspedale Di Circolo, Fondazione Macchi, University Hospital, Varese, Italy;
,
Luigi RigacciHematology Department AOU Careggi, Firenze, Italy
&
Lisa ArgnaniInstitute of Hematology “L. E A. Seràgnoli”, University of Bologna, Bologna, Italy;
show all
Pages 2370-2374 | Received 01 Nov 2015, Accepted 25 Dec 2015, Published online: 17 Feb 2016

References

  • Istodax [package insert]. Summit, NJ: Celgene Corporation; 2014.
  • NCCN Clinical Practice Guidelines in Oncology. Non-Hodgkin’s lymphoma, V.2.2015; [cited 2015 Mar 23]. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  • Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006;5:769–784.
  • Khan O, La Thangue NB. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol Cell Biol. 2012;90:85–94.
  • Marsoni S, Damia G, Camboni G. A work in progress: the clinical development of histone deacetylase inhibitors. Epigenetics. 2008;3:164–171.
  • New M, Olzscha H, La Thangue NB. HDAC inhibitor-based therapies: can we interpret the code? Mol Oncol. 2012;6:637–656.
  • Bradner JE, West N, Grachan ML, et al. Chemical phylogenetics of histone deacetylases. Nat Chem Biol. 2010;6:238–243.
  • Piekarz RL, Frye R, Turner M, et al. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol. 2009;27: 5410–5417.
  • Whittaker SJ, Demierre MF, Kim EJ, et al. Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma. J Clin Oncol. 2010;28:4485–4491.
  • Coiffier B, Pro B, Prince HM, et al. Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy. J Clin Oncol. 2012;30:631–636.
  • Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17: 1244–1253.
  • Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579–586.
  • Coiffier B, Pro B, Prince HM, et al. Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses. J Hematol Oncol. 2014;7:11.
  • O'Connor OA, Horwitz S, Masszi T, et al. Belinostat in patients with relapsed or refractory peripheral T-cell lymphoma: results of the Pivotal Phase II BELIEF (CLN-19) Study. J Clin Oncol. 2015;33:2492–2499.
  • Olsen EA, Kim YH, Kuzel TM, et al. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J Clin Oncol. 2007;25:3109–3115.
  • Duvic M, Talpur R, Ni X, et al. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood. 2007;109:31–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.